Fenn did run the company on the back of a shoestring, not enough people looking at governance, compliance and risk. that seems to be the general consensus.
Not enough focus on getting sufficient employees, too much spend on attorneys and contract review without any focus on how the contracts were being managed,
Michael Ferguson might be dealt with externally at this rate. it is a very poor look that the company has not done enough about Ferguson or KPMG.
Like leaving the bomb ticking inside HQ?
- Forums
- ASX - By Stock
- Ann: Fitch Rating Update
DOW
downer edi limited
Add to My Watchlist
0.64%
!
$6.31

Fenn did run the company on the back of a shoestring, not enough...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.31 |
Change
0.040(0.64%) |
Mkt cap ! $4.237B |
Open | High | Low | Value | Volume |
$6.36 | $6.38 | $6.29 | $7.298M | 1.154M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9995 | $6.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.36 | 10529 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 6.250 |
1 | 100 | 6.220 |
1 | 90 | 6.200 |
1 | 2502 | 6.100 |
1 | 2487 | 6.030 |
Price($) | Vol. | No. |
---|---|---|
6.390 | 2395 | 1 |
6.400 | 7494 | 5 |
6.450 | 7518 | 2 |
6.480 | 132 | 1 |
6.490 | 1970 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
DOW (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online